Quest Diagnostics Incorporated
DGX
Rang in Aktien
#934
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Aktienkurs
$234.71
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$25.91B
Veränderung (1 Tag)
-1.76%
Veränderung (1 Jahr)
23.85%
Land
US
Handel Quest Diagnostics Incorporated (DGX)
Kategorie
Healthcare
Operative Marge für Quest Diagnostics Incorporated (DGX)
Operative Marge zum October 2026 TTM: 14.14%
Laut den neuesten Finanzberichten und dem Aktienkurs von Quest Diagnostics Incorporated beträgt die aktuelle operative Marge (TTM) 14.14%. Am Ende des Jahres 2024 lag die operative Marge bei 13.63%.
Historie der operativen Marge von Quest Diagnostics Incorporated von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 14.14% | -2.68% |
| 2025 | 14.53% | 6.60% |
| 2024 | 13.63% | -0.07% |
| 2023 | 13.64% | -5.61% |
| 2022 | 14.45% | -34.53% |
| 2021 | 22.07% | 5.65% |
| 2020 | 20.89% | 31.14% |
| 2019 | 15.93% | 8.96% |
| 2018 | 14.62% | -3.24% |
| 2017 | 15.11% | -11.07% |
| 2016 | 16.99% | -9.00% |
| 2015 | 18.67% | 41.23% |
| 2014 | 13.22% | -35.95% |
| 2013 | 20.64% | 26.86% |
| 2012 | 16.27% | 22.79% |
| 2011 | 13.25% | -24.63% |
| 2010 | 17.58% | -3.57% |
| 2009 | 18.23% | 8.13% |
| 2008 | 16.86% | 3.56% |
| 2007 | 16.28% | -9.51% |
| 2006 | 17.99% | 2.27% |
| 2005 | 17.59% | 0.06% |
| 2004 | 17.58% | 4.71% |
| 2003 | 16.79% | 16.44% |
| 2002 | 14.42% | 27.16% |
| 2001 | 11.34% | 22.07% |
| 2000 | 9.29% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 17.97% | -98.73% |
US
|
|
| 20.42% | -98.56% |
US
|
|
| -10.70% | -100.76% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.43% |
US
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.